What Does Globus Medical (GMED) CE Mark Approval Mean For Its Europe Launch?

Globus Medical (NYSE: GMED) received CE Mark approval for its Excelsius3D imaging system, clearing the way for commercial launch in the European Union and the United Kingdom. The approval expands regulatory clearance for Globus Medical’s Excelsius platform into new European markets. Excelsius3D is part of the company’s enabling technologies portfolio that targets advanced surgical procedures. For a broader view of where surgical technology and related infrastructure are heading, consider…Read More